HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12-month deferral policy for men who have sex with men.
Whitney R SteeleRoger Y DoddEdward P NotariJames HaynesSteven A AndersonAlan E WilliamsRita ReikDebra KesslerBrian S CusterSusan L Stramernull nullPublished in: Transfusion (2021)
Repeat, first-time, and overall donor incidence did not vary significantly comparing pre-MSM to either of the post-MSM estimation intervals. Residual risk estimates vary by study, but all yield residual risks in the United States of ≤1 per million, and thus far have not shown increasing risk with the 12-month MSM policy change.